Status:
COMPLETED
Mindfulness- Based Intervention for Systemic Lupus Erythematosus (SLE) Patients
Lead Sponsor:
Bar-Ilan University, Israel
Conditions:
Psychological
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Systemic lupus erythematosus (SLE) is a rheumatic autoimmune disease, involving chronic pain, fatigue, movement difficulties, and is often accompanied by tremendous psychological and psychiatric diffi...
Detailed Description
Systemic lupus erythematosus (SLE) Systemic lupus erythematosus (SLE) is an inflammatory autoimmune disease, fluctuates between mild to severe, involving chronic fatigue, Joint pain, stiffness and swe...
Eligibility Criteria
Inclusion
- confirmation of a clinical diagnosis of Lupus by the patient's own physician
- age 18 years or older
- Hebrew speakers
- physical ability to attend group intervention sessions
- psychological ability to practice mindfulness (no cognitive extreme impairments, no psychosis, no suicidal tendencies)
Exclusion
- serious mental health condition (such as suicidal state, alcohol and drug abuse, schizophrenia)
- serious physical condition that would not enable participation
- participation in another study.
Key Trial Info
Start Date :
January 23 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 8 2018
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT04305418
Start Date
January 23 2017
End Date
September 8 2018
Last Update
March 12 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Chaim Sheba Medical Center
Ramat Gan, Israel, 52621
2
Bar- Ilan University
Ramat Gan, Israel, 5290002